-
Arcadia Biosciences Could Nearly Double, Credit Suisse Says
Tuesday, June 9, 2015 - 11:25am | 283In a report published Tuesday, Credit Suisse analyst Christopher Parkinson initiated coverage of Arcadia Biosciences Inc (NASDAQ: RKDA) with an Outperform rating and $14 price target, as the company is a "best-in-class" agricultural technology company that is poised to benefit from the secular need...